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1. Introduction 
 
This chapter will discuss the optimization of a multiple immunostaining method for 
studying the distribution of calcium binding proteins in neural tissue. We discuss the 
different possibilities for brain collection and tissue preservation. Then we present a basic 
protocol for a multicolor immunostaining technique. 
Interference from autofluorescence is one of the major problems in immunofluorescence 
analysis of neural tissue. This difficulty is experienced even when using laser-scanning 
microscopy, which can eliminate out of focus light but not undesirable tissue-specific 
autofluorescence that is in focus. Therefore, we will center our discussion on different 
strategies to minimize neural tissue autofluorescence. The two greatest sources of 
autofluorescence discussed here are those induced by aldehyde fixation and by the 
fluorescent pigment lipofuscin, which accumulates with age in the cytoplasm of cells of the 
central nervous system. Finally, it is important to determine whether any treatments used to 
minimize autofluorescence might quench specific fluorescent compounds used to label the 
proteins of interest. We present the results of multi-label fluorescence immunostaining of 
cryostat sections of 20 µm of the human inferior colliculus. We conclude that the use of 
chemical agents to reduce autofluorescence and quench lipofuscin-specific fluorescence 
helps to maximize the fluorescent signal-to-noise ratio in immunocytochemical studies of 
fixed neural tissues. 
 
2. Antigen preservation of human brain material 
 
Preservation of antigens in brain tissue is one of the major methodological problems of 
immunohistochemical studies. Various premortem events have a negative effect on antigen 
preservation in human brain tissue, such as prolonged agonal state, hypoxia, acidosis, fever 
and seizures. Factors related to postmortem events are the time between death and fixation 
(postmortem delay), temperature variations in cadaver storage, freshness and composition 
of the fixative solutions. 
Postmortem delay is the most important difference between experimentally controlled 
animal models and human tissue (Hilbig et al., 2004). Indeed, optimal protocols for rapidly 
fixing central nervous tissue, such as intravascular infusion of fixative into deeply 
anesthetized animals (Selever et al., 2011), are essential for prevention of enzymatic 
degradation and antigen loss (Martin & O’Callaghan, 1995). However, human tissues are 
usually obtained only several hours after death. Fresh human tissue is sometimes obtained 
during surgery, but such tissue is usually pathologically altered and cannot be used to draw 
conclusions about normal physiology. Brain banks remain the best source of high quality 
postmortem human brain tissue for neuropathological studies and other research (McKee, 
1999; Waldvogel et al., 2006; Ravid & Grinberg, 2008; Waldvogel et al., 2008). 
For qualitative immunohistochemical analysis, a postmortem delay longer than one day is 
usually acceptable, but two crucial controls are needed if protein expression levels are to be 
estimated from immunofluorescence results. First, it is necessary to study the degradation 
profile of the antigens of interest in order to identify the postmortem period during which 
the antigens are stable. Indeed, different antigens are affected differently by postmortem 
catabolic processes (De Groot et al., 1995; Fodor et al., 2002; Hilbig et al., 2004). Second, the 
specimens must be rigorously matched, e.g., for age, sex, postmortem delay and fixation 
time. 
The most common method for preserving antigen for fluorescence microscopy is immersion 
in cross-linking agents, such as formaldehyde and glutaraldehyde. In general, 4% 
formaldehyde in PBS (pH 7.4) made from freshly depolymerized paraformaldehyde is 
preferred, because treatment with glutaraldehyde may mask amine-containing epitopes, 
making immunostaining impossible (Willingham, 1999). It is sufficient to incubate small 
tissue pieces in the fixative overnight at 4°C. For minimal effects on antibody binding, brain 
material should be fixed as short a time as possible consistent with good preservation. 
Fixation for not more than two weeks with refreshment of the fixative every third day has 
been shown to be successful in immunochemical studies (Romijn et al., 1999). Freshly made 
paraformaldehyde induces a lower background autofluorescence than glutaraldehyde or 
pre-prepared formalin. How fixative-induced autofluorescence can be reduced is the subject 
of section 6.1. 
 
3. Storage and sectioning of tissue 
Cryoprotection is used to prevent freezing artifacts and loss of tissue architecture. Once 
properly fixed, the brain tissue is immersed in a graded series of sucrose solutions (10%, 
20% and 30% in PBS pH 7.4) at 4°C, until the tissue sinks to the bottom of the container. The 
sucrose acts as a partial dehydrating substance that protects the tissue against freezing 
artifacts caused by ice crystal formation when the tissue is frozen (Tokuyasu, 1973). 
Morphology and immunoreactivity are generally preserved for up to six months when the 
brain tissue is stored at 4°C in buffered 30% sucrose (supplemented with 0.05% NaN3 to 
prevent growth of bacteria) (Romijn et al., 1999). For longer-term storage, freezing in a 30% 
sucrose solution in PBS at –80°C has been shown to reasonably preserve the hypothalamus 
and to cause only minimal freeze artifacts (Romijn et al., 1999). Gathering even a small 
number of human brain tissue samples usually takes weeks or months. Therefore, to 
perform a reliable, comparative immunocytochemical study, the brain tissue usually needs 
to be stored frozen. 
Before sectioning, the embedded tissue blocks are equilibrated at –20°C for at least one hour. 
Section thickness is important. Sections that are too thin may be very fragile and tear when 
handled in long protocols, whereas thick sections have a higher intensity of 
autofluorescence (Del Castillo et al., 1989). After sectioning, the tissues are rehydrated for at 
least 40 minutes in TBS or PBS buffer (pH 7.4) before further treatment. Rehydration is done 
on floating tissue sections or on sections adhered to coated slides. 
 
4. Multi-label fluorescence immunostaining 
 
Two antigens can be simultaneously detected in the same tissue section by incubating 
unconjugated primary antibodies of different origin, followed by labeling with fluorophore-
conjugated secondary antibodies against the primary antibodies. This strategy can be more 
sensitive than directly labeled primary antibodies due to signal amplification through 
multiple secondary antibody reactions with different antigenic sites on the primary 
antibody. Higher signal-to-noise ratios can also be achieved through the use of new 
generation fluorophores such as AlexaFluor and Dylight, which are brighter and more 
photostable than their older counterparts (e.g. FITC, TRITC). Various controls should be run 
to verify the specificity of the antibodies in order to avoid false-positive results due to non-
specific binding or to recognition of epitopes shared by different molecules. Negative 
controls should include incubation in non-immune mouse IgG or normal rabbit serum 
instead of the primary antibody, omission of the primary and/or the secondary antibody 
and pre-adsorption of the antibody with an excess of purified antigen. Controls can also be 
sections from other tissues or brain regions known to contain (positive control) or to lack 
(negative control) the protein of interest. Staining is deemed specific only if both negative 
and positive controls give unequivocal results. Neurons and other cells present in neural 
tissue can also be visualized by combining the previous protocol with neuron specific 
reagents such as NeurotraceTM fluorescent Nissl stains and DAPI or Hoechst 33258 DNA 
stains. 
When primary antibodies from different species are not available, methods for multiple 
immunolabeling with primary antibodies originating from the same host species can be 
used (Buchwalow et al., 2005; Frisch et al., 2011). Moreover, when greater sensitivity is 
required amplification methods such as the tyramide signal amplification method or avidin-
biotin complexing can be employed (Brouns et al., 2002; Tóth & Mezey, 2007; Bratthauer, 
2010). 
In Section 2 we have mentioned the importance of using rigorously matching brains in 
quantitative studies (see Section 2). In addition, the matching samples need to be processed 
and evaluated simultaneously using the same solutions. In this way, large differences in 
intensity between conditions can be shown. However, the results should be confirmed by 
truly quantitative methods, such as western blot. 
 
5. Confocal laser scanning microscopy 
 
The use of confocal fluorescence microscopy to analyze multiple immunolabeled sections 
has several advantages over conventional methods. First, confocal microscopy can filter out-
of-focus light to yield sharp, high-contrast images of thick samples. In addition, by collecting 
2-D images from different planes in the tissue, a volume of tissue can be reconstructed in 3-
D. Another advantage is that since most systems are equipped with multiple lasers of 
different wavelengths, they can excite a set of fluorescent probes spanning nearly the full 
range of visible wavelengths, allowing multiprobe imaging of the specimen (Dailey et al., 
1999). 
Nevertheless, confocal microscopy will not eliminate non-specific background fluorescence, 
which is a main problem in adult human neural tissue. Indeed, imaging of neural tissue is 
usually not satisfactory due to the broad emission spectrum of the autofluorescence which 
can overlap the specific fluorescent labels. An example of autofluorescence in a human brain 
tissue sample is shown in Figure 1. Therefore, the protocol should be optimized for multiple 
fluorescent immunolabeling by treating the samples as described in section 6 in order to 
improve the visualization of the fluorochromes of interest. 
 
6. Non-specific background fluorescence or autofluorescence 
 
Autofluorescence is a common problem in aged human brain tissue and when present 
decreases the signal-to-noise ratio of specific labeling. The main causes of autofluorescence 
in the central nervous system are artifacts due to fixation and endogenous causes such as the 
fluorescent pigment lipofuscin, which accumulates as cells age. 
 
6.1. Evaluation of fixative-induced fluorescence 
 
The most common method to fix tissue for fluorescence microscopy is immersion in cross-
linking agents, such as formaldehyde and glutaraldehyde. The aldehydes form covalent 
bonds between adjacent amine-containing groups through a Schiff acid-base reaction, which 
leads to formation of methylene bridges and other types of links (Collins & Goldsmith, 1981; 
Fox et al., 1985). However, unreacted aldehyde groups fluoresce efficiently at the same 
wavelengths as many of the fluorescent probes employed for immunofluorescence assays. 
Since glutaraldehyde possesses two functional groups per molecule while formaldehyde has 
only one, background autofluorescence is more problematic for tissues fixed with 
glutaraldehyde. To keep the background autofluorescence as low as possible in 
immunocytochemistry, the preferred buffer for fixing tissue is 4% formaldehyde in PBS (pH 
7.4) made from freshly depolymerized paraformaldehyde. Fixative-related autofluorescence 
is visualized as fairly uniform broad spectrum fluorescence and may be brighter in some 
cells than in others, depending on the presence of biogenic amines (Clancy & Cauller, 1998). 
Fixative-induced autofluorescence may be circumvented by quenching unreacted 
aldehydes. A common method is to pretreat fixed sections with reducing agents, such as 
freshly prepared NaBH4 (1% w/v) in PBS for 10–20 min at 4°C (Willingham 1983; Beisker et  
  
Fig. 1. Punctate autofluorescent structures in a 20-µm sagittal section from the human 
inferior colliculus exposed to the same laser power for the blue (A), green (B), red (C) and 
deep-red (D) channels. The lipofuscin-related autofluorescence is less visible in the blue 
channel and strongest in the deep-red channel. The wide overlap in the blue, green, red and 
deep-red channels supports previous studies showing that lipofuscin has broad spectral 
properties (Kikugawa et al., 1997; Schnell et al., 1999; Zhang et al., 2010). Magnification = 
63x; scale bar = 20 µm 
 
Fig. 2. Effect of incubation under control conditions (A–D), 1% (E–H) or 10% sodium 
borohydride (I–L) on the background fluorescence in 20-µm consecutive sections of the 
human inferior colliculus stained with DAPI and visualized in the blue (A, E, I), green 
(B,F,J), red (C, G, K), and deep-red (D, H, L) channels by confocal microscopy. Incubation in 
NaBH4 resulted in a small decrease of the background autofluorescence in each channel, 
indicating that un-reduced aldehydes induced by tissue fixation ( 4% paraformaldehyde in 
PBS pH 7.4 for two weeks at 4°C) were not substantially contributing to non-specific 
background. Magnification 20x; scale bar = 100 µm 
 
al., 1987; Tagliaferro et al., 1997; Figure 2) to reduce free aldehyde groups to alcohols. Care 
should be taken when using NaBH4 solution because it is very caustic and can cause 
explosions due to release of hydrogen. Alternatively, fixed sections may be treated with 
exogenous amine-containing reagents, such as: 50 mM NH4Cl in PBS for 5–10 min, or in 
100–300 mM glycine in Tris buffer pH 7.4 or PBS for 1–2 h at 4°C (Callis 2010; Ngwenya et 
al., 2005). The best method should be determined empirically. These techniques can be used 
alone or sequentially. If the tissue is fragile, the glycine method is advised. 
 
6.2. Reduction of lipofuscin autofluorescence 
 
Lipofuscin is a ubiquitous fluorescent pigment that accumulates with age in long-lived cells, 
such as neurons and cardiac myocytes (Brizzee et al., 1974). The topographical and temporal 
patterns of lipofuscin production vary throughout the brain (Mann & Yates, 1987; Peters et 
al., 1991). However, the development of lipofuscin generally begins during infancy, from the 
age of three or four months (Porta, 2002), becomes obvious in human neurons at the age of 
nine years (Sulzer et al., 2008), and is present in most cortical neurons and glial cells by the 
age of thirty years (Benavides et al., 2002). This pigment may occupy up to 75% of the 
perikaryon of some neurons in the aged brain (Terman & Brunk, 1998). Lipofuscin in 
neurons appears to be derived primarily from the breakdown of autophagocytosed 
mitochondria into a polymer of oxidatively modified protein residues bridged by acid and 
lipid residues (Terman & Brunk, 2004, 2006). Mature large lipofuscin granules are found 
mainly in the perinuclear area but may occasionally be present in the perikaryon, dendrites, 
axons and even presynaptic areas (Riga et al., 2006). 
Under light microscopy, lipofuscin appears yellow-brown or translucent. Under the electron 
microscope, it appears as a homogeneously dark, irregular mass often containing small lipid 
droplets, and is surrounded by a single membrane (Harman, 1989). When visualized by a 
fluorescence or laser-scanning microscope, lipofuscin appears as tiny, punctate intracellular 
structures that are strongly fluorescent over a wide spectral range (excitation 350–580 nm; 
emission 400–650 nm). The excitation maximum, about 400 nm, yields a broad emission 
spectra for lipofuscin granules between 530 and 650 nm, which overlaps with the commonly 
used fluorophores (Hyden & Lidstrom, 1950; Eldred et al., 1982; Katz et al., 1984; Porta, 
2002; Haralampus-Grynaviski et al., 2003; Double et al., 2008; Figure 1) and thereby 
interferes with specific immunofluorescent signals. When the fluorescence of antibody–
fluorochrome complexes is weak, it is important to unequivocally discriminate between 
nonspecific (lipofuscin) and specific fluorescence. Four distinct lipofuscin fluorescence 
spectra have been reported in a sodium dodecyl sulfate extract of rat kidneys: blue 
fluorescence with excitation/emission maxima at 360/440 nm, respectively, greenish 
fluorescence at 460/530 nm, and yellow fluorescence at 400/620 nm and 580/620 nm. The 
yellow fluorescence at 400/620 nm accumulates with aging, and its excitation and emission 
maxima are close to those observed histochemically under a fluorescence microscope 
(Kikugawa et al., 1997).  
Treatment of neural tissue with the lipophilic dye Sudan Black B and CuSO4 have been 
consistently reported to be useful in quenching the yellow 400/620 nm fluorescence of the 
lipofuscin to very low levels without substantially affecting the specific fluorescence of the 
fluorochromes coupled to secondary antibodies (Kikugawa et al., 1997; Brehmer et al., 2004; 
Schnell et al., 1999; Romijn et al., 1999; Oliveira et al., 2010; Zhang et al., 2010). Moreover, the 
Autofluorescence Eliminator Reagent from Chemicon International reduces lipofuscin 
autofluorescence. This reagent consists of a solution of Sudan Black (and possibly other 
components) in ethanol. One drawback of treating tissues to reduce lipofuscin-related 
autofluorescence is reduction of the fluorescent signal from the introduced fluorophore. 
Therefore, it is important to check to what extent the treatment affects the fluorescent signal 
and choose the method accordingly. 
An example of human serial sections of the inferior colliculus treated with Sudan Black B 
and CuSO4 is shown in Figure 3. Sudan Black B treatment was done according to Kiernan 
(1981), as cited in Romijn et al. (1999), who prescribed dissolving the dye by stirring 0.3% 
Sudan Black B in 70% ethanol at room temperature in the dark for two hours and leaving it 
standing overnight before filtering it, after which it can be stored in the dark at 4°C for at 
least two months. After immunolabeling the sections, the solution is applied for 10 minutes 
at room temperature and then the sections are rinsed rapidly eight times in TBS. Another 
protocol consists of treating the tissue with CuSO4 according to (Schnell et al., 1999). After 
immunocytochemistry, the sections are taken out of TBS and dipped briefly in distilled 
water, followed by treatment with 1 mM CuSO4 in 50 nM ammonium acetate buffer (pH 5.0) 
for 10–30 min, a brief dip in distilled water, and a return to TBS. The samples were 
coverslipped using 25 mg/ml DABCO dissolved in MowiolR 4-88 as mounting media. 
Application of CuSO4 for 10 minutes after immunohistochemistry substantially reduced 
tissue autofluorescence while preserving the specific fluorochrome signals. The overall 
background fluorescence increased substantially when the samples were treated with Sudan 
Black B, especially when using the 543-nm laser (Figure 3, panel K). The increase in 
background fluorescence in the samples treated with Sudan Black B could be related to the 
DABCO antifading agent in the tissue mounting media, as previously observed by Romijn 
et al., 1999. The commercial product Vectashield and the antifading agent p-phenylene-
diamine dissolved in glycerol also react similarly (Romijn et al., 1999). If Sudan Black B is 
used to decrease the lipofuscin-induced autofluorescence, Tris-buffered glycerol at a pH of 
7.0–7.6 (not higher) is recommended as the best mounting medium. 
 
7. Quenching fluorescence by non-specific protein adsorption 
 
The most commonly used method to reduce background staining due to non-
immunological binding of the specific immune sera by hydrophobic interaction is to use a 
protein blocking solution before application of the primary antibody. The solution should 
contain proteins similar to those present in the secondary antibody but not resembling those 
in the primary antibody. Bovine serum albumin (BSA) is probably the most widely used 
blocking agent for reducing non-specific binding due to hydrophobic interaction, but non-
fat dry milk, casein, fish skin gelatin, horse serum and goat serum have also been 
recommended (Duhamel & Johnson, 1985; Kaur et al., 2002). However, blocking agents can 
also cause problems. A decrease in NeurotraceTM fluorescence has been reported after 
incubating the samples in the presence of bovine serum albumin, non fat dried milk or horse 
serum (reported in the manufacturer’s web page 
http://probes.invitrogen.com/media/pis/mp21480.pdf). An alternative to these reagents is 
fish skin gelatin. However, in our experience, bovine serum albumin (3%) or fish skin 
gelatin (2%) quenched the fluorescence of NeurotraceTM at 1/200 dilution, which made it 
 
Fig. 3. Effect on lipofuscin autofluorescence in sections of the human inferior colliculus 
under control conditions (A–D) and after treatment with 1 mM CuSO4 in 50 mM ammonium 
acetate buffer (pH 5.0) (E–H) or 0.3% Sudan Black B in 70% ethanol (I–L)  and visualized in 
the blue (A, E, I), green (B,F,J), red (C, G, K), and deep-red (D, H, L) channels by confocal 
microscopy. Magnification 20x; scale bar = 100 µm 
necessary to use a higher concentration of NeurotraceTM (1/100) to achieve adequate 
staining in 20-µm sagittal sections of the human inferior colliculus (data not shown). 
Doubling of the deep-red NeurotraceTM concentration yielded correct fluorescence staining 
when blocking was done with BSA or FSG for the deep-red fluorochrome. No substantial 
differences in fluorescence intensity were observed when BSA or FSG was used for blocking 
for the other fluorochromes employed, i.e. AF488, AF586, and DAPI (Figure 4). Thus, 
blocking in a neutral protein solution such as BSA or FSG decreases background of primary 
and secondary antibodies successfully, but requires a higher concentration of NeurotraceTM 
for optimal staining. In previous experiments (data not shown) higher concentrations of 
blocking proteins also produced increased background staining, so this should be optimized 
for different tissue types. In general beginning with 0.5% blocking protein is recommended 
and testing higher concentrations if necessary to block non-specific protein absorption. 
 
8. Basic protocol for multiple immunostaining in neural tissue using 
antibodies of different species 
 
 Obtain human brain tissue as quickly as possible after death (less than one day 
preferred). 
 Fix the tissue with freshly prepared 4% paraformaldehyde in phosphate buffered 
saline (PBS; pH 7.4) for not more than two weeks at 4°C in the dark. Refresh the 
fixative every three days. Overnight fixation for small (<1 cm3) tissue pieces is 
sufficient. Freshness of the fixative and the incubation conditions are of great 
importance to avoid autofluorescence. 
 Immerse the tissue in 10% sucrose in PBS (pH 7.4) at 4°C until the tissue sinks. Repeat 
the procedure with 20% sucrose and then with 30% sucrose. 
 Freeze the tissue in a cryo-embedding medium such as OCT and store it in an air tight 
container at –80°C. 
 At least one hour before sectioning, equilibrate the tissue blocks at –20°C. Sections are 
cut, rehydrated and washed in Tris buffered saline (TBS) for at least 40 minutes 
immediately before any treatment. TBS is used for all washes and dilutions, but other 
buffers such as PBS may also be used. To minimize autofluorescence, make the 
sections as thin as possible; i.e. 15-20 µm. Wash the floating sections in TBS for 3 x 5 
minutes.  
 Permeabilize the sections by immersion in 0.5% Triton X-100 in TBS for 30 min at 4°C 
in the dark. Wash the floating sections in TBS for 3 x 5 minutes. 
 For blocking, incubate the sections in a mixture of 0.5% serum from the species that the 
secondary antibody was raised in and 1% fish skin gelatin (or 0,5% BSA) in TBS for one 
hour at room temperature. 
 To reduce fixative-induced autofluorescence, if necessary, pretreat the fixed sections 
with 1% NaBH4 in PBS for 10–20 min, or 50 mM NH4Cl in PBS for 5–10 min, or 100–300 
mM glycine in TBS or PBS pH 7.4 for one or two hours at 4°C. If the tissue is fragile, it 
is better to use glycine. 
 Blot excess blocking solution from sections and incubate overnight at 4°C with a 
mixture of appropriately diluted primary antibodies in TBS containing 1% FSG (or 
0.5% BSA).  
 Wash sections in 1% FSG (or 0.5% BSA) in TBS for 4x15 min. Incubate sections 
overnight at 4°C with a mixture of secondary fluorophore-conjugated antibodies raised 
against the corresponding species of primary antibodies in 1% FSG (or 0.5% BSA). 
Adding 0.5% Tween-20 into the secondary antibody dilution aids to reduce nonspecific 
staining (Sun et al., 2009). Wash sections in TBS for 4 x 15 min. 
 Counterstain neurons if necessary, e.g. with 1/100 dilution of deep-red NeurotraceTM 
(Invitrogen), for 30 min at room temperature followed by rinsing for 2 h in TBS. Then, 
counterstain nuclei if necessary, e.g., with 1 µg/ml DAPI in TBS for 3 min at room 
temperature. Wash sections in TBS for 3x5 min. 
 Reduce lipofuscin-induced autofluorescence by rinsing briefly with distilled water 
then incubating the samples for 10–60 min with a solution of 1 mM CuSO4 in 50 mM 
ammonium acetate buffer (pH 5). Rinse quickly in distilled water and wash eight times 
in TBS. Alternatively, the samples can be treated for 10 min with 0.3% Sudan Black B in 
70% ethanol. 
 Place the sections on a slide and mount with a mixture of glycerol/PBS (9:1, v/v) 
supplemented with an antifading agent, e.g. 25 mg/ml 1,4-diaza-bicyclo[2.2.2]octane 
(DABCO) or 0.5% n-propylgallate (pH 7.4). Do not use anti-fade mounting media on 
samples treated with Sudan Black B. 
 An example of human brain tissue multi-labeled as described in this section is shown 
in Figures 5-7. Briefly, the inferior colliculi were fixed with 4% paraformaldehyde, 
sectioned at 20 µm, incubated in a pooled primary antibody solution containing mouse 
anti-parvalbumin monoclonal antibody (2.2 µg/ml; P3088, Sigma-Aldrich, Bornem, 
Belgium) and rabbit anti-calretinin polyclonal antibody (0.8 µg/ml; C7479, Sigma-
Aldrich) diluted in 1% FSG, followed by incubation in AlexaFluor 488 donkey-anti-
mouse and AlexaFluor 568 donkey anti-rabbit from Invitrogen (15 µg/ml). The figures 
also show samples counterstained with deep-red NeurotraceTM (1/100 dilution) and 
DAPI (1 µg/ml) before treatment with CuSO4 for 10 minutes as described in this 
section. While lipofuscin-induced autofluorescence is no longer observed in the blue, 
green and red channel, it is still an issue in the deep-red channel. The remaining 
autofluorescence in the deep-red channel is possibly related to the weak fluorescent 
signal detected upon staining with deep-red NeurotraceTM, especially in small neurons 
of the dorsal cortex. 
 
9. Conclusion 
 
In this chapter we discuss multiple-label fluorescence confocal microscopy and methods to 
reduce autofluorescence in sections of the human central nervous system. We also evaluate 
the quenching of fluorescence by non-specific protein adsorption. We conclude that 
treatment of neural tissues with reagents to reduce endogenous autofluorescence is helpful 
in improving specific signal-to-noise ratios. Sections processed in this way are suitable for 
examining the complex structure and organization of human brain tissue. 
 
Fig. 4. Effect of bovine serum albumin (BSA) (A–C; G–I) and fish skin gelatin (FSG) (D–F; J–
L) on fluorochrome intensity as visualized by confocal microscopy in the blue (A, D, G, J), 
green (B,E), red (H, K), and deep-red (C, F, I, L) channels. The sections were blocked with 
2% BSA or 3% FSG before incubation with mouse anti-parvalbumin (2.2 µg/ml; P3088, 
Sigma) and appropriate secondary antibodies labeled with the fluorochrome AlexaFluor 488 
(15 µg/ml; A11059, Invitrogen) or AlexaFluor 568 (15 µg/ml; A10037, Invitrogen). The 
samples were subsequently stained with NeurotraceTM (1/100 dilution) and DAPI (15 
µg/ml). Lipofuscin autofluorescence was then reduced with CuSO4 as previously reported 
(see section 6.2.). No differences were observed in the intensity of the various fluorochromes 
when blocked with BSA or FSG. Magnification 20x; scale bar = 100 µm 
  
Fig. 5. 2-D reconstruction of confocal micrographs of a 20-µm sagittal section of the human 
inferior colliculus. The sections were stained for the nuclei with DAPI (A), for calretinin with 
AlexaFluor 488 (B), for parvalbumin with AlexaFluor 568 (C), and for neurons with deep-red 
NeurotraceTM (D). A light microscopy image shows an overview of the inferior colliculus 
(E). Parvalbumin positive cells are located at the central nucleus (CN) of the inferior 
colliculus while calretinin positive cells are less abundant and located at the dorsal cortex 
(DC) as previously reported (Sharma et al., 2009; Tardif et al., 2003). Magnification 20x; bar= 
2 mm 
 
 
Fig. 6. Detail of a parvalbumin positive cell located at the central nucleus of the human 
inferior colliculus. The sections were stained as detailed in figure 5. Magnification 63x; bar= 
20 µm 
 
Fig. 7. Detail of a calretinin positive cell located at the dorsal cortex of the human inferior 
colliculus. The sections were stained as detailed in figure 5. Magnification 63x; bar= 20 µm 
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